News
MassVentures START Grants Award $4.5M to 26 Startups
MassVentures START Grants provide $4.5M to fund 26 innovative Massachusetts startups, significantly accelerating their deep-tech sector growth.

MassVentures and the Healey-Driscoll Administration announced on August 13, 2026, that $4.5 million in SBIR Targeted Technologies (START) Grants would be awarded to 26 Massachusetts startups across life sciences, robotics, artificial intelligence, quantum computing, clean energy and other growing sectors. The announcement marks another milestone for a program designed to translate federally funded research into commercial ventures that create jobs across the Commonwealth. The news underscores Massachusetts’ continued emphasis on backing deep-tech startups that leverage university and hospital research to drive regional economic growth.
MassVentures, the state’s quasi-public venture fund, uses START Grants to support non-dilutive funding that bridges the gap between research milestones and market-readiness. The 2026 round, announced jointly by the Healey-Driscoll administration and MassVentures, demonstrates the state’s ongoing commitment to nurturing innovative companies that otherwise face capital gaps in early commercialization. This year’s awards highlight a broad mix of technologies and geographies within Massachusetts, illustrating the statewide reach of the program. As MassVentures notes, the START program has, since its inception, channeled millions of dollars into dozens of startups that have gone on to raise private capital and scale manufacturing, sales, and jobs across the state. This broader context helps readers understand why START remains a central piece of Massachusetts’ innovation policy. (Sources: MassVentures START Grants 2026 Awardees press release; MassVentures START program information page.) (mass-ventures.com)
What we’re seeing in August 2026 is a continuation of a carefully calibrated funding ladder designed to push Massachusetts-based deep-tech firms from laboratory results toward market entry. The START program’s architecture—16 Stage I grants of $100,000, 7 Stage II grants of $200,000, and 3 Stage III grants of $500,000—was designed to provide escalating support as startups mature their commercial plans and regulatory or manufacturing milestones come into sharper focus. The 2026 funding breakdown, as announced by MassVentures and the Commonwealth, shows a disciplined deployment of non-dilutive capital intended to accelerate product development and job creation across multiple sectors. The program’s long track record, dating back to 2012, includes $46.2 million in START grants awarded to 157 companies, a figure that underscores the cumulative impact of a program viewed as a cornerstone of Massachusetts’ tech ecosystem. (mass-ventures.com)
Anchor to the event: MassVentures and the Healey-Driscoll Administration announced $4.5 million in START Grants to 26 Massachusetts startups on August 13, 2026. The news release details the program’s structure, the Stage I–III award tiers, and the wide range of technologies being funded. This central fact is the headline of today’s coverage and is the foundation for the rest of this report. To read the official release, see the MassVentures page describing 2026 START awardees, and the companion press materials that explain the grant amounts and recipient categories in detail. (mass-ventures.com)
Section 1: What Happened
2026 START Grant Awards: An Overview
The August 13, 2026 announcement framed the START Grant awards as a pivotal step in translating federally funded SBIR and STTR research into market-ready products and Massachusetts-based jobs. The press materials emphasize that START grants range from $100,000 to $500,000, with the Stage III awards capped at $500,000 per company. The 2026 cohort includes 16 Stage I recipients, 7 Stage II recipients, and 3 Stage III recipients, totaling 26 startups that will benefit from non-dilutive funding plus strategic guidance. The announcement reinforces that these grants are designed to fill critical gaps not covered by federal support, including activities like market development, IP strategy, and early-stage manufacturing planning. The 2026 round aligns with multi-year state objectives to expand the state’s deep-tech economy and diversify the startup ecosystem beyond the immediate Boston-Cambridge corridor. (Primary sources: MassVentures START Grants press release; MassVentures START program information page.) (mass-ventures.com)
Stage III Winners: The Largest Grants
In this year’s cohort, the three Stage III awardees each receive $500,000 to propel commercialization efforts for their breakthrough technologies. The list of Stage III winners includes Bloomer Tech, Emvolon, and PhagePro. Bloomer Tech focuses on addressing cardiovascular risk in women with a wearable, data-driven approach; Emvolon is advancing carbon-negative fuels and chemicals derived from greenhouse gas emissions; PhagePro is pursuing bacteriophage-based therapeutics to prevent bacterial outbreaks. The Stage III design, with its higher level of funding, signals confidence in these teams’ ability to reach significant commercial milestones within a defined timeframe. The release notes that Stage III funding acts as a catalyst for subsequent investment rounds and larger manufacturing deployments. (Primary source: MassVentures press release.) (mass-ventures.com)
Stage II and Stage I Winners: Broadening the Innovation Envelope
Stage II awards of $200,000 went to AutonomUS Medical Technologies (handheld device blending AI, ultrasound, and robotics), Enigma Aerospace (autonomous cargo aircraft), Highland Instruments (ESStim noninvasive brain stimulation), Nanopath (plasmonic biosensing for point-of-care diagnostics), Optigon (high-speed research and inspection tools), Qunett (quantum hardware for networks), and Sangtera (electrostatic actuation for robotics and packaging). Stage II winners represent a cross-section of Massachusetts’ assets in AI, robotics, quantum tech, and health tech, illustrating how START seeks to balance high-potential science with near-term commercial plans. Stage I winners, receiving $100,000 each, include AiRANACULUS, BioDevek, CranioSense, EvoDenovo, GelSight, InnoTech Precision Medicine, Koi Biotherapeutics, Limax Biosciences, Matrisome Bio, Myrias Optics, Optical Waters, RISE Robotics, rStream, SpaceRake, Valis Insights, and Venova Technologies. These early-stage awards are designed to de-risk critical activities that make later-stage fundraising more attractive to private capital. The full roster of Stage I and Stage II recipients demonstrates the broad geographic and sectoral reach of START in 2026. (Primary source: MassVentures START Grants 2026 awardees page; press release excerpt) (mass-ventures.com)
The Funding Scale and What It Means for Recipients
MassVentures notes that START grants provide non-dilutive capital that funds capabilities not fully covered by federal awards. In practice, the Stage I grants typically support activities like early market validation, IP strategy, and initial regulatory planning; Stage II funds advance product development, clinical or field trials where applicable, and manufacturing readiness; Stage III grants aim to accelerate commercialization by addressing scale-up, large-scale validation, and final go-to-market strategies. The three-tier structure is intended to reward progress with larger awards as milestones are achieved, enabling startups to translate technical breakthroughs into market-ready products that can attract follow-on private investment and partnerships. The 2026 announcement reiterates that the Commonwealth’s investment is designed to shorten the time-to-market for deep-tech startups and to diversify the regional innovation footprint beyond traditional hubs. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
A Brief Snapshot of the Past: START’s Track Record
To contextualize the 2026 awards, it’s helpful to recall that MassVentures has, since launching START in 2012, awarded $46.2 million to 157 companies that have since raised more than $5 billion in private capital and employed more than 3,400 people. This history underscores START’s track record of helping research-derived technologies move from the lab to real-world impact, a central theme echoed in the 2026 release. The program’s reach across the state—more than 40 locations outside Boston and Cambridge—highlights the Commonwealth’s distributed approach to nurturing innovation. (Primary source: MassVentures press release; START program information page) (mass-ventures.com)
Section 2: Why It Matters
Economic Impact: Jobs, Capital, and Regional Development
The START awards are positioned as catalysts for job creation and the broader infusion of private capital into Massachusetts’ deep-tech ecosystem. The 26 startups funded in 2026 span life sciences, AI, robotics, quantum computing, and clean energy, reflecting a diversification of the Commonwealth’s high-growth sectors. The press release notes that previous START cohorts have created thousands of jobs and attracted billions in private capital, signaling a sustained multiplicative effect on the regional economy. Beyond individual company milestones, the program contributes to a robust pipeline of talent, research translation, and regional entrepreneurial ecosystems that extend well beyond the major metro centers. This aligns with the state’s broader strategy to leverage university and hospital research networks as engines of economic growth. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
Geographic and Sectoral Distribution: A Statewide Footprint
MassVentures emphasizes the geographic diversity of the awarded startups. While a notable concentration remains in the Boston-Cambridge corridor, the 2026 cohort includes companies based in Woburn, Cambridge, Burlington, Lowell, Mansfield, Mansfield, Natick, and other Massachusetts locales. The distribution underscores the program’s mission to spread high-potential opportunities across the Commonwealth and to support regional clusters that can benefit from early-stage capital and mentorship. The inclusion of Stage I winners in smaller cities and towns illustrates the program’s inclusive approach to funding and its potential to unlock regional value in manufacturing, healthcare, and technology services. (Primary source: 2026 awardees list on MassVentures site) (mass-ventures.com)
Innovation Momentum Across Sectors: What the Winners Say
The 2026 cohort spans environmental tech (Bloomer Tech; Emvolon), health tech (BioDevek; InnoTech Precision Medicine; Koi Biotherapeutics), and advanced manufacturing (Optigon; RISE Robotics; SpaceRake). The breadth signals Massachusetts’ continued commitment to supporting a wide spectrum of deep-tech innovations—from materials science to biotech and next-generation communications. The accompanying quotes from state leaders underscore a coordinated policy effort to keep the state at the vanguard of technology commercialization, with START functioning as a practical tool for turning scientific discoveries into scalable businesses that create jobs. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
Policy Context: START as a Bridge within Massachusetts’ Innovation Economy
START is one of several grant and funding programs designed to complement the state’s venture capital and research ecosystems. By providing non-dilutive funding alongside business guidance, START helps companies de-risk early-stage work and position themselves for subsequent rounds of private investment, strategic partnerships, and, in some cases, public-sector contracts. The program’s alignment with SBIR/STTR frameworks reinforces Massachusetts’ strategy of leveraging federal research investments to build domestic, export-ready capabilities across critical sectors. The 2026 announcements also reflect ongoing public-private collaboration, with recognition from state leaders about the importance of maintaining a strong pipeline of globally competitive deep-tech firms. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
Section 3: What’s Next
Next Application Window: Planning for 2027
Looking ahead, the MassVentures START Grants program has signaled a new application window, with the next submission period anticipated to open February 1, 2027. The program’s information hub confirms the cadence and structure of the START grants, including the staged award framework and eligibility criteria for Massachusetts-based startups that have previously secured SBIR Phase II or STTR Phase II awards. For readers and companies watching the Massachusetts tech scene, the February 2027 window will be a critical moment to align strategy around milestone achievements that make an application compelling. (Primary sources: START program information page; February 1, 2027 opening date) (mass-ventures.com)
What to Watch: Indicators of Momentum and Opportunity
Several indicators will help observers gauge the impact and trajectory of the START program in the coming years:
- Recurrence and scale of Stage III awards: A consistent streak of $500,000 Stage III awards would signal a maturity in the market where more companies are reaching commercialization milestones sooner.
- Geographic spread: A continuing trend toward broader geographic dispersion would strengthen the hypothesis that startup activity and job creation are not confined to the usual innovation hubs but are spreading to smaller cities and towns.
- Follow-on private capital: The historical track record showing billions in private capital raised after START participation will continue to be a critical barometer of program effectiveness.
- Industry mix: Ongoing diversification across life sciences, AI, quantum computing, and clean energy would reinforce Massachusetts’ role as a broad-based deep-tech powerhouse. (Primary sources: MassVentures START program information page; 2026 START grant announcements) (mass-ventures.com)
What’s the takeaway for investors, policymakers, researchers, startups, and regional economic development leaders? START grants are more than one-off awards; they are deliberate inflection points in a longer-term strategy to convert research investments into scalable, job-creating enterprises. The 2026 cohort reinforces the model: targeted, staged funding that aligns with clear milestones, backed by public leadership that sees technology commercialization as a strategic engine for Massachusetts’ economy. The public-facing statements from Governor Healey, Lt. Governor Driscoll, and Secretary Paley emphasize the state’s willingness to back dynamic teams with the potential to redefine industries and generate durable regional growth. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
Closing
As Massachusetts continues to prioritize translational research and startup-scale outcomes, the 2026 START Grants round exemplifies how public-private collaboration can accelerate the path from lab to market. The 26 recipients collectively represent a snapshot of the Commonwealth’s innovation ecosystem at a moment when government funding, venture capital, and university technology transfer networks intersect to drive regional prosperity. Readers should stay tuned for 2027 updates, including the February application window and potential milestones that will shape the next wave of awards. For ongoing coverage, follow MassVentures’ updates and official state announcements, which will provide continued visibility into how these investments translate into new products, new companies, and new jobs across Massachusetts. (Primary sources: MassVentures press release; START program information page) (mass-ventures.com)
Notes on context and sources
- This piece relies on MassVentures’ official 2026 START award announcements and program information to ground the reporting in primary materials. The central event date is August 13, 2026, when the state announced the $4.5 million grant package to 26 startups. Readers can verify the Stage I–III award structure, the recipient list, and the total award amount through the official MassVentures release and the START program information page. (Primary sources: MassVentures press release; SBIR Targeted Technologies "START" Grants information page.) (mass-ventures.com)
About the author
Nadia Osei
Nadia Osei writes about research, culture and sport for Daily Bostonian: the universities and teaching hospitals, the museums and music, and the teams that set the mood of a Boston week.